Global Genetic Engineering Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Genetic Engineering Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Genetic Engineering Drug industry chain, the market status of Medicine (Monoclonal Antibody, Recombinant Human Erythropoietin), Research (Monoclonal Antibody, Recombinant Human Erythropoietin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Genetic Engineering Drug.
Regionally, the report analyzes the Genetic Engineering Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Genetic Engineering Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Genetic Engineering Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Genetic Engineering Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Recombinant Human Erythropoietin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Genetic Engineering Drug market.
Regional Analysis: The report involves examining the Genetic Engineering Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Genetic Engineering Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Genetic Engineering Drug:
Company Analysis: Report covers individual Genetic Engineering Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Genetic Engineering Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medicine, Research).
Technology Analysis: Report covers specific technologies relevant to Genetic Engineering Drug. It assesses the current state, advancements, and potential future developments in Genetic Engineering Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Genetic Engineering Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Genetic Engineering Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Genetic Engineering Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Genetic Engineering Drug, with price, sales, revenue and global market share of Genetic Engineering Drug from 2019 to 2024.
Chapter 3, the Genetic Engineering Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genetic Engineering Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Genetic Engineering Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Genetic Engineering Drug.
Chapter 14 and 15, to describe Genetic Engineering Drug sales channel, distributors, customers, research findings and conclusion.
Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Genetic Engineering Drug industry chain, the market status of Medicine (Monoclonal Antibody, Recombinant Human Erythropoietin), Research (Monoclonal Antibody, Recombinant Human Erythropoietin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Genetic Engineering Drug.
Regionally, the report analyzes the Genetic Engineering Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Genetic Engineering Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Genetic Engineering Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Genetic Engineering Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Recombinant Human Erythropoietin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Genetic Engineering Drug market.
Regional Analysis: The report involves examining the Genetic Engineering Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Genetic Engineering Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Genetic Engineering Drug:
Company Analysis: Report covers individual Genetic Engineering Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Genetic Engineering Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medicine, Research).
Technology Analysis: Report covers specific technologies relevant to Genetic Engineering Drug. It assesses the current state, advancements, and potential future developments in Genetic Engineering Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Genetic Engineering Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Genetic Engineering Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monoclonal Antibody
- Recombinant Human Erythropoietin
- Recombinant Human Interferon
- Recombinant Human Growth Hormone
- Recombinant Human Insulin
- Medicine
- Research
- Industrial
- Agriculture
- Other
- Shanghai Lansheng Guojian Pharmaceutical
- Biotech Pharmaceutical
- Anhui Anke Biotechnology
- GeneScience Pharmaceuticals
- Beijing SL Pharmaceutical
- Jiangsu Sihuan Bioengineering
- Shenzhen Neptunus Interlong Bio-Technique
- 3SBio
- Tonghua Dongbao Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Genetic Engineering Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Genetic Engineering Drug, with price, sales, revenue and global market share of Genetic Engineering Drug from 2019 to 2024.
Chapter 3, the Genetic Engineering Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genetic Engineering Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Genetic Engineering Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Genetic Engineering Drug.
Chapter 14 and 15, to describe Genetic Engineering Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Genetic Engineering Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Genetic Engineering Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibody
1.3.3 Recombinant Human Erythropoietin
1.3.4 Recombinant Human Interferon
1.3.5 Recombinant Human Growth Hormone
1.3.6 Recombinant Human Insulin
1.4 Market Analysis by Application
1.4.1 Overview: Global Genetic Engineering Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Medicine
1.4.3 Research
1.4.4 Industrial
1.4.5 Agriculture
1.4.6 Other
1.5 Global Genetic Engineering Drug Market Size & Forecast
1.5.1 Global Genetic Engineering Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Genetic Engineering Drug Sales Quantity (2019-2030)
1.5.3 Global Genetic Engineering Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shanghai Lansheng Guojian Pharmaceutical
2.1.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.1.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
2.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
2.2 Biotech Pharmaceutical
2.2.1 Biotech Pharmaceutical Details
2.2.2 Biotech Pharmaceutical Major Business
2.2.3 Biotech Pharmaceutical Genetic Engineering Drug Product and Services
2.2.4 Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biotech Pharmaceutical Recent Developments/Updates
2.3 Anhui Anke Biotechnology
2.3.1 Anhui Anke Biotechnology Details
2.3.2 Anhui Anke Biotechnology Major Business
2.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
2.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Anhui Anke Biotechnology Recent Developments/Updates
2.4 GeneScience Pharmaceuticals
2.4.1 GeneScience Pharmaceuticals Details
2.4.2 GeneScience Pharmaceuticals Major Business
2.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
2.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
2.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
2.6 Jiangsu Sihuan Bioengineering
2.6.1 Jiangsu Sihuan Bioengineering Details
2.6.2 Jiangsu Sihuan Bioengineering Major Business
2.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
2.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Sihuan Bioengineering Recent Developments/Updates
2.7 Shenzhen Neptunus Interlong Bio-Technique
2.7.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.7.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
2.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Genetic Engineering Drug Product and Services
2.8.4 3SBio Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 3SBio Recent Developments/Updates
2.9 Tonghua Dongbao Pharmaceutical
2.9.1 Tonghua Dongbao Pharmaceutical Details
2.9.2 Tonghua Dongbao Pharmaceutical Major Business
2.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
2.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GENETIC ENGINEERING DRUG BY MANUFACTURER
3.1 Global Genetic Engineering Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Genetic Engineering Drug Revenue by Manufacturer (2019-2024)
3.3 Global Genetic Engineering Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Genetic Engineering Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Genetic Engineering Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Genetic Engineering Drug Manufacturer Market Share in 2023
3.5 Genetic Engineering Drug Market: Overall Company Footprint Analysis
3.5.1 Genetic Engineering Drug Market: Region Footprint
3.5.2 Genetic Engineering Drug Market: Company Product Type Footprint
3.5.3 Genetic Engineering Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Genetic Engineering Drug Market Size by Region
4.1.1 Global Genetic Engineering Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Genetic Engineering Drug Consumption Value by Region (2019-2030)
4.1.3 Global Genetic Engineering Drug Average Price by Region (2019-2030)
4.2 North America Genetic Engineering Drug Consumption Value (2019-2030)
4.3 Europe Genetic Engineering Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Genetic Engineering Drug Consumption Value (2019-2030)
4.5 South America Genetic Engineering Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Genetic Engineering Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Genetic Engineering Drug Sales Quantity by Type (2019-2030)
5.2 Global Genetic Engineering Drug Consumption Value by Type (2019-2030)
5.3 Global Genetic Engineering Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Genetic Engineering Drug Sales Quantity by Application (2019-2030)
6.2 Global Genetic Engineering Drug Consumption Value by Application (2019-2030)
6.3 Global Genetic Engineering Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Genetic Engineering Drug Sales Quantity by Type (2019-2030)
7.2 North America Genetic Engineering Drug Sales Quantity by Application (2019-2030)
7.3 North America Genetic Engineering Drug Market Size by Country
7.3.1 North America Genetic Engineering Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Genetic Engineering Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Genetic Engineering Drug Sales Quantity by Type (2019-2030)
8.2 Europe Genetic Engineering Drug Sales Quantity by Application (2019-2030)
8.3 Europe Genetic Engineering Drug Market Size by Country
8.3.1 Europe Genetic Engineering Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Genetic Engineering Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Genetic Engineering Drug Market Size by Region
9.3.1 Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Genetic Engineering Drug Sales Quantity by Type (2019-2030)
10.2 South America Genetic Engineering Drug Sales Quantity by Application (2019-2030)
10.3 South America Genetic Engineering Drug Market Size by Country
10.3.1 South America Genetic Engineering Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Genetic Engineering Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Genetic Engineering Drug Market Size by Country
11.3.1 Middle East & Africa Genetic Engineering Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Genetic Engineering Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Genetic Engineering Drug Market Drivers
12.2 Genetic Engineering Drug Market Restraints
12.3 Genetic Engineering Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Genetic Engineering Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Genetic Engineering Drug
13.3 Genetic Engineering Drug Production Process
13.4 Genetic Engineering Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Genetic Engineering Drug Typical Distributors
14.3 Genetic Engineering Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Genetic Engineering Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Genetic Engineering Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibody
1.3.3 Recombinant Human Erythropoietin
1.3.4 Recombinant Human Interferon
1.3.5 Recombinant Human Growth Hormone
1.3.6 Recombinant Human Insulin
1.4 Market Analysis by Application
1.4.1 Overview: Global Genetic Engineering Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Medicine
1.4.3 Research
1.4.4 Industrial
1.4.5 Agriculture
1.4.6 Other
1.5 Global Genetic Engineering Drug Market Size & Forecast
1.5.1 Global Genetic Engineering Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Genetic Engineering Drug Sales Quantity (2019-2030)
1.5.3 Global Genetic Engineering Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shanghai Lansheng Guojian Pharmaceutical
2.1.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.1.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
2.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
2.2 Biotech Pharmaceutical
2.2.1 Biotech Pharmaceutical Details
2.2.2 Biotech Pharmaceutical Major Business
2.2.3 Biotech Pharmaceutical Genetic Engineering Drug Product and Services
2.2.4 Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biotech Pharmaceutical Recent Developments/Updates
2.3 Anhui Anke Biotechnology
2.3.1 Anhui Anke Biotechnology Details
2.3.2 Anhui Anke Biotechnology Major Business
2.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
2.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Anhui Anke Biotechnology Recent Developments/Updates
2.4 GeneScience Pharmaceuticals
2.4.1 GeneScience Pharmaceuticals Details
2.4.2 GeneScience Pharmaceuticals Major Business
2.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
2.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
2.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
2.6 Jiangsu Sihuan Bioengineering
2.6.1 Jiangsu Sihuan Bioengineering Details
2.6.2 Jiangsu Sihuan Bioengineering Major Business
2.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
2.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Sihuan Bioengineering Recent Developments/Updates
2.7 Shenzhen Neptunus Interlong Bio-Technique
2.7.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.7.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
2.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Genetic Engineering Drug Product and Services
2.8.4 3SBio Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 3SBio Recent Developments/Updates
2.9 Tonghua Dongbao Pharmaceutical
2.9.1 Tonghua Dongbao Pharmaceutical Details
2.9.2 Tonghua Dongbao Pharmaceutical Major Business
2.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
2.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GENETIC ENGINEERING DRUG BY MANUFACTURER
3.1 Global Genetic Engineering Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Genetic Engineering Drug Revenue by Manufacturer (2019-2024)
3.3 Global Genetic Engineering Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Genetic Engineering Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Genetic Engineering Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Genetic Engineering Drug Manufacturer Market Share in 2023
3.5 Genetic Engineering Drug Market: Overall Company Footprint Analysis
3.5.1 Genetic Engineering Drug Market: Region Footprint
3.5.2 Genetic Engineering Drug Market: Company Product Type Footprint
3.5.3 Genetic Engineering Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Genetic Engineering Drug Market Size by Region
4.1.1 Global Genetic Engineering Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Genetic Engineering Drug Consumption Value by Region (2019-2030)
4.1.3 Global Genetic Engineering Drug Average Price by Region (2019-2030)
4.2 North America Genetic Engineering Drug Consumption Value (2019-2030)
4.3 Europe Genetic Engineering Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Genetic Engineering Drug Consumption Value (2019-2030)
4.5 South America Genetic Engineering Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Genetic Engineering Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Genetic Engineering Drug Sales Quantity by Type (2019-2030)
5.2 Global Genetic Engineering Drug Consumption Value by Type (2019-2030)
5.3 Global Genetic Engineering Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Genetic Engineering Drug Sales Quantity by Application (2019-2030)
6.2 Global Genetic Engineering Drug Consumption Value by Application (2019-2030)
6.3 Global Genetic Engineering Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Genetic Engineering Drug Sales Quantity by Type (2019-2030)
7.2 North America Genetic Engineering Drug Sales Quantity by Application (2019-2030)
7.3 North America Genetic Engineering Drug Market Size by Country
7.3.1 North America Genetic Engineering Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Genetic Engineering Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Genetic Engineering Drug Sales Quantity by Type (2019-2030)
8.2 Europe Genetic Engineering Drug Sales Quantity by Application (2019-2030)
8.3 Europe Genetic Engineering Drug Market Size by Country
8.3.1 Europe Genetic Engineering Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Genetic Engineering Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Genetic Engineering Drug Market Size by Region
9.3.1 Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Genetic Engineering Drug Sales Quantity by Type (2019-2030)
10.2 South America Genetic Engineering Drug Sales Quantity by Application (2019-2030)
10.3 South America Genetic Engineering Drug Market Size by Country
10.3.1 South America Genetic Engineering Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Genetic Engineering Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Genetic Engineering Drug Market Size by Country
11.3.1 Middle East & Africa Genetic Engineering Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Genetic Engineering Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Genetic Engineering Drug Market Drivers
12.2 Genetic Engineering Drug Market Restraints
12.3 Genetic Engineering Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Genetic Engineering Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Genetic Engineering Drug
13.3 Genetic Engineering Drug Production Process
13.4 Genetic Engineering Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Genetic Engineering Drug Typical Distributors
14.3 Genetic Engineering Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Genetic Engineering Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Genetic Engineering Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 5. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
Table 6. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
Table 8. Biotech Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Biotech Pharmaceutical Major Business
Table 10. Biotech Pharmaceutical Genetic Engineering Drug Product and Services
Table 11. Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biotech Pharmaceutical Recent Developments/Updates
Table 13. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 14. Anhui Anke Biotechnology Major Business
Table 15. Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
Table 16. Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Anhui Anke Biotechnology Recent Developments/Updates
Table 18. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. GeneScience Pharmaceuticals Major Business
Table 20. GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
Table 21. GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GeneScience Pharmaceuticals Recent Developments/Updates
Table 23. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Beijing SL Pharmaceutical Major Business
Table 25. Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
Table 26. Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Beijing SL Pharmaceutical Recent Developments/Updates
Table 28. Jiangsu Sihuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Sihuan Bioengineering Major Business
Table 30. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
Table 31. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Jiangsu Sihuan Bioengineering Recent Developments/Updates
Table 33. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base and Competitors
Table 34. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 35. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
Table 36. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
Table 38. 3SBio Basic Information, Manufacturing Base and Competitors
Table 39. 3SBio Major Business
Table 40. 3SBio Genetic Engineering Drug Product and Services
Table 41. 3SBio Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. 3SBio Recent Developments/Updates
Table 43. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Tonghua Dongbao Pharmaceutical Major Business
Table 45. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
Table 46. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 48. Global Genetic Engineering Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Genetic Engineering Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Genetic Engineering Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Genetic Engineering Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Genetic Engineering Drug Production Site of Key Manufacturer
Table 53. Genetic Engineering Drug Market: Company Product Type Footprint
Table 54. Genetic Engineering Drug Market: Company Product Application Footprint
Table 55. Genetic Engineering Drug New Market Entrants and Barriers to Market Entry
Table 56. Genetic Engineering Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Genetic Engineering Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Genetic Engineering Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Genetic Engineering Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Genetic Engineering Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Genetic Engineering Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Genetic Engineering Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Genetic Engineering Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Genetic Engineering Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Genetic Engineering Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Genetic Engineering Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Genetic Engineering Drug Raw Material
Table 116. Key Manufacturers of Genetic Engineering Drug Raw Materials
Table 117. Genetic Engineering Drug Typical Distributors
Table 118. Genetic Engineering Drug Typical Customers
Table 1. Global Genetic Engineering Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Genetic Engineering Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 5. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
Table 6. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
Table 8. Biotech Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Biotech Pharmaceutical Major Business
Table 10. Biotech Pharmaceutical Genetic Engineering Drug Product and Services
Table 11. Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biotech Pharmaceutical Recent Developments/Updates
Table 13. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 14. Anhui Anke Biotechnology Major Business
Table 15. Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
Table 16. Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Anhui Anke Biotechnology Recent Developments/Updates
Table 18. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. GeneScience Pharmaceuticals Major Business
Table 20. GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
Table 21. GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GeneScience Pharmaceuticals Recent Developments/Updates
Table 23. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Beijing SL Pharmaceutical Major Business
Table 25. Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
Table 26. Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Beijing SL Pharmaceutical Recent Developments/Updates
Table 28. Jiangsu Sihuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Sihuan Bioengineering Major Business
Table 30. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
Table 31. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Jiangsu Sihuan Bioengineering Recent Developments/Updates
Table 33. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base and Competitors
Table 34. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 35. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
Table 36. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
Table 38. 3SBio Basic Information, Manufacturing Base and Competitors
Table 39. 3SBio Major Business
Table 40. 3SBio Genetic Engineering Drug Product and Services
Table 41. 3SBio Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. 3SBio Recent Developments/Updates
Table 43. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Tonghua Dongbao Pharmaceutical Major Business
Table 45. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
Table 46. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 48. Global Genetic Engineering Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Genetic Engineering Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Genetic Engineering Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Genetic Engineering Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Genetic Engineering Drug Production Site of Key Manufacturer
Table 53. Genetic Engineering Drug Market: Company Product Type Footprint
Table 54. Genetic Engineering Drug Market: Company Product Application Footprint
Table 55. Genetic Engineering Drug New Market Entrants and Barriers to Market Entry
Table 56. Genetic Engineering Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Genetic Engineering Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Genetic Engineering Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Genetic Engineering Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Genetic Engineering Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Genetic Engineering Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Genetic Engineering Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Genetic Engineering Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Genetic Engineering Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Genetic Engineering Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Genetic Engineering Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Genetic Engineering Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Genetic Engineering Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Genetic Engineering Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Genetic Engineering Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Genetic Engineering Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Genetic Engineering Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Genetic Engineering Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Genetic Engineering Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Genetic Engineering Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Genetic Engineering Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Genetic Engineering Drug Raw Material
Table 116. Key Manufacturers of Genetic Engineering Drug Raw Materials
Table 117. Genetic Engineering Drug Typical Distributors
Table 118. Genetic Engineering Drug Typical Customers
LIST OF FIGURES
Figure 1. Genetic Engineering Drug Picture
Figure 2. Global Genetic Engineering Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Genetic Engineering Drug Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody Examples
Figure 5. Recombinant Human Erythropoietin Examples
Figure 6. Recombinant Human Interferon Examples
Figure 7. Recombinant Human Growth Hormone Examples
Figure 8. Recombinant Human Insulin Examples
Figure 9. Global Genetic Engineering Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Genetic Engineering Drug Consumption Value Market Share by Application in 2023
Figure 11. Medicine Examples
Figure 12. Research Examples
Figure 13. Industrial Examples
Figure 14. Agriculture Examples
Figure 15. Other Examples
Figure 16. Global Genetic Engineering Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Genetic Engineering Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Genetic Engineering Drug Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Genetic Engineering Drug Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Genetic Engineering Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Genetic Engineering Drug Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Genetic Engineering Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Genetic Engineering Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Genetic Engineering Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Genetic Engineering Drug Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Genetic Engineering Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Genetic Engineering Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Genetic Engineering Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 58. China Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Genetic Engineering Drug Market Drivers
Figure 79. Genetic Engineering Drug Market Restraints
Figure 80. Genetic Engineering Drug Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2023
Figure 83. Manufacturing Process Analysis of Genetic Engineering Drug
Figure 84. Genetic Engineering Drug Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Genetic Engineering Drug Picture
Figure 2. Global Genetic Engineering Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Genetic Engineering Drug Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody Examples
Figure 5. Recombinant Human Erythropoietin Examples
Figure 6. Recombinant Human Interferon Examples
Figure 7. Recombinant Human Growth Hormone Examples
Figure 8. Recombinant Human Insulin Examples
Figure 9. Global Genetic Engineering Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Genetic Engineering Drug Consumption Value Market Share by Application in 2023
Figure 11. Medicine Examples
Figure 12. Research Examples
Figure 13. Industrial Examples
Figure 14. Agriculture Examples
Figure 15. Other Examples
Figure 16. Global Genetic Engineering Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Genetic Engineering Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Genetic Engineering Drug Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Genetic Engineering Drug Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Genetic Engineering Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Genetic Engineering Drug Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Genetic Engineering Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Genetic Engineering Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Genetic Engineering Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Genetic Engineering Drug Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Genetic Engineering Drug Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Genetic Engineering Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Genetic Engineering Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Genetic Engineering Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 58. China Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Genetic Engineering Drug Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Genetic Engineering Drug Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Genetic Engineering Drug Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Genetic Engineering Drug Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Genetic Engineering Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Genetic Engineering Drug Market Drivers
Figure 79. Genetic Engineering Drug Market Restraints
Figure 80. Genetic Engineering Drug Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2023
Figure 83. Manufacturing Process Analysis of Genetic Engineering Drug
Figure 84. Genetic Engineering Drug Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
